Current and Future Development in Lung Cancer Diagnosis
Lung cancer is the leading cause of cancer-related deaths in North America and other developed countries. One of the reasons lung cancer is at the top of the list is that it is often not diagnosed until the cancer is at an advanced stage. Thus, the earliest diagnosis of lung cancer is crucial, espec...
Saved in:
| Published in | International journal of molecular sciences Vol. 22; no. 16; p. 8661 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
12.08.2021
MDPI |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Lung cancer is the leading cause of cancer-related deaths in North America and other developed countries. One of the reasons lung cancer is at the top of the list is that it is often not diagnosed until the cancer is at an advanced stage. Thus, the earliest diagnosis of lung cancer is crucial, especially in screening high-risk populations, such as smokers, exposure to fumes, oil fields, toxic occupational places, etc. Based on the current knowledge, it looks that there is an urgent need to identify novel biomarkers. The current diagnosis of lung cancer includes different types of imaging complemented with pathological assessment of biopsies, but these techniques can still not detect early lung cancer developments. In this review, we described the advantages and disadvantages of current methods used in diagnosing lung cancer, and we provide an analysis of the potential use of body fluids as carriers of biomarkers as predictors of cancer development and progression. |
|---|---|
| AbstractList | Lung cancer is the leading cause of cancer-related deaths in North America and other developed countries. One of the reasons lung cancer is at the top of the list is that it is often not diagnosed until the cancer is at an advanced stage. Thus, the earliest diagnosis of lung cancer is crucial, especially in screening high-risk populations, such as smokers, exposure to fumes, oil fields, toxic occupational places, etc. Based on the current knowledge, it looks that there is an urgent need to identify novel biomarkers. The current diagnosis of lung cancer includes different types of imaging complemented with pathological assessment of biopsies, but these techniques can still not detect early lung cancer developments. In this review, we described the advantages and disadvantages of current methods used in diagnosing lung cancer, and we provide an analysis of the potential use of body fluids as carriers of biomarkers as predictors of cancer development and progression. Lung cancer is the leading cause of cancer-related deaths in North America and other developed countries. One of the reasons lung cancer is at the top of the list is that it is often not diagnosed until the cancer is at an advanced stage. Thus, the earliest diagnosis of lung cancer is crucial, especially in screening high-risk populations, such as smokers, exposure to fumes, oil fields, toxic occupational places, etc. Based on the current knowledge, it looks that there is an urgent need to identify novel biomarkers. The current diagnosis of lung cancer includes different types of imaging complemented with pathological assessment of biopsies, but these techniques can still not detect early lung cancer developments. In this review, we described the advantages and disadvantages of current methods used in diagnosing lung cancer, and we provide an analysis of the potential use of body fluids as carriers of biomarkers as predictors of cancer development and progression.Lung cancer is the leading cause of cancer-related deaths in North America and other developed countries. One of the reasons lung cancer is at the top of the list is that it is often not diagnosed until the cancer is at an advanced stage. Thus, the earliest diagnosis of lung cancer is crucial, especially in screening high-risk populations, such as smokers, exposure to fumes, oil fields, toxic occupational places, etc. Based on the current knowledge, it looks that there is an urgent need to identify novel biomarkers. The current diagnosis of lung cancer includes different types of imaging complemented with pathological assessment of biopsies, but these techniques can still not detect early lung cancer developments. In this review, we described the advantages and disadvantages of current methods used in diagnosing lung cancer, and we provide an analysis of the potential use of body fluids as carriers of biomarkers as predictors of cancer development and progression. |
| Author | Nooreldeen, Reem Bach, Horacio |
| AuthorAffiliation | Division of Infectious Diseases, Faculty of Medicine, The University of British Columbia, Vancouver, BC V6H 3Z6, Canada; reemnooreldeen@gmail.com |
| AuthorAffiliation_xml | – name: Division of Infectious Diseases, Faculty of Medicine, The University of British Columbia, Vancouver, BC V6H 3Z6, Canada; reemnooreldeen@gmail.com |
| Author_xml | – sequence: 1 givenname: Reem surname: Nooreldeen fullname: Nooreldeen, Reem – sequence: 2 givenname: Horacio orcidid: 0000-0002-7740-9299 surname: Bach fullname: Bach, Horacio |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34445366$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkUFPGzEQha0KVCDtrWe0EhcOBOyx11lfKlUBWqRIXOjZmtje4GjXTu1dpP57HIVUKUJz8Mj-5s3zzBk5CjE4Qr4xes25ojd-3WcAJhsp2SdyygTAlFI5OzrIT8hZzmtKgUOtPpMTLoSouZSnZDYfU3JhqDDY6n4cxuSqW_fiurjpt9c-VIsxrKo5BuNSdetxFWL2-Qs5brHL7uvbOSG_7--e5r-mi8efD_Mfi6kRs2aYtg2yGkW7tMKotgWKaMA6CwaRY4PKtExaaGsFxijJ-FIyB9YqgSit5XxCvu90N-Oyd9YUTwk7vUm-x_RXR_T6_5fgn_UqvuiGq5orUQQu3wRS_DO6POjeZ-O6DoOLY9ZQS0nLnErvCbl4h67jmEL5ngYJogSwWaHODx39s7KfaQFgB5gUc06u1cYPOPi4Neg7zajeLk4fLq4UXb0r2ut-iL8ChNqatQ |
| CitedBy_id | crossref_primary_10_3389_fonc_2024_1339036 crossref_primary_10_3390_ijms242115995 crossref_primary_10_1155_2024_9987322 crossref_primary_10_3389_fgene_2022_1054132 crossref_primary_10_1155_2022_2731744 crossref_primary_10_1186_s40001_023_01581_x crossref_primary_10_1016_j_asjsur_2024_01_002 crossref_primary_10_1155_2023_3028869 crossref_primary_10_1186_s12890_024_03060_3 crossref_primary_10_1109_ACCESS_2024_3524564 crossref_primary_10_1016_j_jprot_2024_105180 crossref_primary_10_3390_biomedicines11020389 crossref_primary_10_1007_s12672_024_01319_z crossref_primary_10_3390_cancers16112146 crossref_primary_10_1016_j_aej_2024_09_033 crossref_primary_10_1155_2022_9270789 crossref_primary_10_1186_s12885_024_12224_7 crossref_primary_10_3390_jcm13061601 crossref_primary_10_3389_fphar_2023_1217213 crossref_primary_10_3390_bios13060627 crossref_primary_10_1007_s12013_024_01349_y crossref_primary_10_1186_s12890_024_02983_1 crossref_primary_10_3389_fmolb_2023_1295955 crossref_primary_10_12677_ACM_2023_134795 crossref_primary_10_3390_diseases12050098 crossref_primary_10_3390_nu16142193 crossref_primary_10_3390_cells14060411 crossref_primary_10_55783_AMF_190804 crossref_primary_10_1007_s10103_024_04176_y crossref_primary_10_1007_s12094_024_03543_z crossref_primary_10_1016_j_biopha_2024_116275 crossref_primary_10_1016_j_cyto_2023_156376 crossref_primary_10_1016_j_eswa_2025_126515 crossref_primary_10_3390_bios14100501 crossref_primary_10_1016_j_advms_2023_10_003 crossref_primary_10_1016_j_jrras_2024_100982 crossref_primary_10_3390_cancers15133414 crossref_primary_10_1038_s41551_024_01340_1 crossref_primary_10_4028_p_cdM8f6 crossref_primary_10_1016_j_intimp_2023_111180 crossref_primary_10_1039_D4CE00406J crossref_primary_10_2174_0115680096337237240909101904 crossref_primary_10_7454_epidkes_v8i2_1110 crossref_primary_10_61186_ijrr_22_2_315 crossref_primary_10_1186_s12957_024_03402_9 crossref_primary_10_1615_CritRevEukaryotGeneExpr_2023046830 crossref_primary_10_1038_s41598_023_38350_z crossref_primary_10_1007_s10103_024_04153_5 crossref_primary_10_1002_mp_17328 crossref_primary_10_1016_j_prp_2024_155156 crossref_primary_10_1021_acs_analchem_3c03135 crossref_primary_10_31083_j_fbl2902080 crossref_primary_10_1088_1361_6528_acd1f2 crossref_primary_10_1007_s12291_024_01214_y crossref_primary_10_1016_j_jtcvs_2023_09_027 crossref_primary_10_4081_mrm_2023_929 crossref_primary_10_3390_s24072161 crossref_primary_10_1002_smll_202206624 crossref_primary_10_1016_j_ab_2022_115031 crossref_primary_10_1186_s12890_023_02350_6 crossref_primary_10_1016_j_apsusc_2025_162985 crossref_primary_10_1088_1752_7163_adab88 crossref_primary_10_1039_D4BM00488D crossref_primary_10_3389_fonc_2023_1090757 crossref_primary_10_3390_cancers16193320 crossref_primary_10_3390_cancers14174121 crossref_primary_10_1016_j_cca_2025_120187 crossref_primary_10_1016_j_compmedimag_2024_102426 crossref_primary_10_1016_j_heliyon_2023_e14129 crossref_primary_10_1002_jcla_24504 crossref_primary_10_3390_jcm13216568 crossref_primary_10_1002_mp_17463 crossref_primary_10_2174_0113894501273651231201061144 crossref_primary_10_1016_j_phymed_2024_155431 crossref_primary_10_1002_ctd2_70011 crossref_primary_10_3892_ijo_2022_5444 crossref_primary_10_3892_ijmm_2024_5394 crossref_primary_10_3389_fonc_2022_1037964 crossref_primary_10_3389_fmed_2022_969487 crossref_primary_10_1007_s00530_024_01579_3 crossref_primary_10_35366_114801 crossref_primary_10_1016_j_compbiomed_2024_108251 crossref_primary_10_1016_j_actbio_2025_01_039 crossref_primary_10_1016_j_tranon_2024_102018 crossref_primary_10_1038_s41435_023_00194_y crossref_primary_10_1016_j_ejphar_2023_176004 crossref_primary_10_1155_2022_2524649 crossref_primary_10_2174_1573398X2002240522161146 crossref_primary_10_1016_j_jare_2024_04_028 crossref_primary_10_3233_THC_240660 crossref_primary_10_1080_07853890_2023_2279748 crossref_primary_10_1016_j_cca_2023_117676 crossref_primary_10_2147_IJGM_S409869 crossref_primary_10_3390_metabo13010028 crossref_primary_10_3390_jcm13154531 crossref_primary_10_2174_1871520623666221107140624 crossref_primary_10_1002_advs_202402580 crossref_primary_10_1515_revac_2023_0068 crossref_primary_10_3389_fphar_2025_1525210 crossref_primary_10_1002_cam4_6503 crossref_primary_10_1016_j_biopha_2024_116207 crossref_primary_10_1002_mp_16316 crossref_primary_10_1002_smll_202405872 crossref_primary_10_1016_j_bbrc_2025_151681 crossref_primary_10_12998_wjcc_v12_i15_2597 crossref_primary_10_3390_cancers15153785 crossref_primary_10_1016_j_biopha_2022_113607 crossref_primary_10_3389_fphar_2023_1230824 crossref_primary_10_1134_S1070428023130092 crossref_primary_10_3390_ijms25179502 crossref_primary_10_1111_apm_13359 crossref_primary_10_3390_cancers17050725 crossref_primary_10_3389_fonc_2024_1428018 crossref_primary_10_3390_cancers15010087 crossref_primary_10_1016_j_ncrna_2024_01_013 crossref_primary_10_3390_biomedicines13030678 crossref_primary_10_3389_fonc_2023_1201713 crossref_primary_10_3389_fonc_2024_1427170 crossref_primary_10_3389_fgene_2022_960229 crossref_primary_10_1007_s12094_024_03475_8 crossref_primary_10_1007_s10753_024_02045_y crossref_primary_10_1016_j_vacune_2024_05_013 crossref_primary_10_1016_j_heliyon_2023_e15812 crossref_primary_10_1155_2023_3965198 crossref_primary_10_1080_10408363_2024_2321202 crossref_primary_10_25259_Cytojournal_146_2024 crossref_primary_10_1002_ptr_8241 crossref_primary_10_16899_jcm_1347963 crossref_primary_10_4103_nah_nah_98_23 crossref_primary_10_1007_s00203_023_03636_3 crossref_primary_10_1007_s40242_024_3246_y crossref_primary_10_1177_15330338221136724 crossref_primary_10_1007_s12033_023_00848_2 crossref_primary_10_1016_j_modpat_2024_100571 crossref_primary_10_1016_j_phymed_2024_156278 crossref_primary_10_3390_life14040462 crossref_primary_10_1021_acs_analchem_4c00794 crossref_primary_10_4252_wjsc_v15_i6_576 crossref_primary_10_1155_2023_6544042 crossref_primary_10_1111_1759_7714_15425 crossref_primary_10_18632_aging_204561 crossref_primary_10_1007_s13577_022_00832_z crossref_primary_10_1016_j_eswa_2025_126596 crossref_primary_10_1016_j_snb_2024_135578 crossref_primary_10_3390_cancers17020285 crossref_primary_10_3390_ijtm4040046 crossref_primary_10_2174_0113895575293544240605112838 crossref_primary_10_1021_acsbiomaterials_4c01323 crossref_primary_10_1016_j_ijbiomac_2024_134587 crossref_primary_10_1002_slct_202402903 crossref_primary_10_3389_fgene_2022_977156 crossref_primary_10_1007_s13187_024_02519_5 crossref_primary_10_1016_j_arr_2024_102576 crossref_primary_10_3892_or_2024_8790 crossref_primary_10_3390_ijms23073631 crossref_primary_10_3390_s24247899 crossref_primary_10_3389_fonc_2024_1453021 crossref_primary_10_3389_fphar_2025_1538601 crossref_primary_10_1002_adbi_202400306 crossref_primary_10_1016_j_ejphar_2024_177131 crossref_primary_10_3390_cancers15204910 crossref_primary_10_3390_cancers16244202 crossref_primary_10_3389_fsurg_2024_1482120 crossref_primary_10_7717_peerj_16195 crossref_primary_10_1186_s12880_024_01442_x crossref_primary_10_3390_healthcare11222920 crossref_primary_10_3389_fimmu_2025_1494708 crossref_primary_10_1007_s11042_024_20009_0 crossref_primary_10_1111_1759_7714_15400 crossref_primary_10_1186_s12890_024_02887_0 crossref_primary_10_3390_ijms241713302 crossref_primary_10_3390_ijms241411861 crossref_primary_10_1016_j_vacun_2023_12_003 crossref_primary_10_1177_20552076241249661 crossref_primary_10_1007_s13167_024_00366_4 crossref_primary_10_1002_cbin_12208 crossref_primary_10_53759_0088_JBSHA20240401 crossref_primary_10_1016_j_heliyon_2023_e20179 crossref_primary_10_1080_13696998_2024_2444781 crossref_primary_10_1186_s12967_024_05411_4 crossref_primary_10_1002_cam4_70156 crossref_primary_10_3389_fphar_2025_1533493 crossref_primary_10_3390_life12101640 crossref_primary_10_1089_jir_2024_0008 crossref_primary_10_3892_ol_2023_13958 crossref_primary_10_3389_fbioe_2024_1385552 crossref_primary_10_1007_s12094_024_03800_1 crossref_primary_10_1016_j_jinorgbio_2025_112902 crossref_primary_10_1007_s42979_023_02432_6 crossref_primary_10_3724_abbs_2024069 crossref_primary_10_1021_acs_analchem_3c03511 crossref_primary_10_37251_jhiee_v1i2_1206 crossref_primary_10_3390_ph17091118 crossref_primary_10_1109_ACCESS_2024_3434592 crossref_primary_10_1097_MD_0000000000033143 crossref_primary_10_1039_D4TB00719K crossref_primary_10_1186_s13020_024_00904_2 crossref_primary_10_1007_s10812_022_01442_1 crossref_primary_10_1016_j_heliyon_2024_e27586 crossref_primary_10_1038_s41598_024_67379_x crossref_primary_10_1016_j_heliyon_2024_e30646 crossref_primary_10_1615_CritRevEukaryotGeneExpr_2024053662 crossref_primary_10_1016_j_mri_2024_01_014 crossref_primary_10_1177_03936155241244802 crossref_primary_10_3389_fonc_2022_955186 crossref_primary_10_70749_ijbr_v2i02_402 crossref_primary_10_4014_jmb_2306_06020 crossref_primary_10_1016_j_surfin_2024_105436 crossref_primary_10_1007_s12668_024_01673_w crossref_primary_10_1021_acsomega_4c10008 crossref_primary_10_1186_s12014_022_09381_x crossref_primary_10_1016_j_intimp_2024_113282 crossref_primary_10_1111_cbdd_14408 crossref_primary_10_3389_fonc_2024_1361879 crossref_primary_10_3390_cancers17060952 crossref_primary_10_1186_s12885_024_12516_y crossref_primary_10_1002_cam4_70048 crossref_primary_10_1128_spectrum_03494_22 crossref_primary_10_1016_j_fraope_2025_100222 crossref_primary_10_1615_CritRevEukaryotGeneExpr_2023047789 crossref_primary_10_1016_j_jddst_2024_106158 crossref_primary_10_1038_s41598_024_61175_3 crossref_primary_10_1111_1759_7714_15383 crossref_primary_10_3389_fonc_2024_1376916 crossref_primary_10_1097_MD_0000000000030970 crossref_primary_10_31083_j_fbl2805095 crossref_primary_10_3390_tomography11030024 crossref_primary_10_1016_j_ijbiomac_2024_135972 crossref_primary_10_1111_crj_13757 crossref_primary_10_1016_j_nanoms_2024_01_010 crossref_primary_10_4081_monaldi_2025_2997 crossref_primary_10_1016_j_puhe_2025_02_024 crossref_primary_10_12998_wjcc_v11_i6_1330 crossref_primary_10_1002_biof_2129 crossref_primary_10_1016_j_clinimag_2023_110070 crossref_primary_10_1007_s12013_023_01180_x crossref_primary_10_1007_s12672_025_01986_6 crossref_primary_10_2478_rrlm_2024_0007 crossref_primary_10_1007_s00109_023_02306_7 crossref_primary_10_1039_D3TB01850D crossref_primary_10_1177_17534666241249168 crossref_primary_10_3390_cancers16061165 crossref_primary_10_1093_labmed_lmac122 crossref_primary_10_62347_BOFP2157 crossref_primary_10_1177_03000605231199763 crossref_primary_10_3390_molecules27196733 crossref_primary_10_1021_acsomega_3c06388 crossref_primary_10_1155_2022_5702014 crossref_primary_10_3390_biomedicines12010123 crossref_primary_10_1016_j_heliyon_2023_e20471 crossref_primary_10_3390_ijms24065272 crossref_primary_10_3389_fonc_2024_1507658 crossref_primary_10_1186_s12935_024_03522_y crossref_primary_10_1016_j_heliyon_2024_e29447 crossref_primary_10_1093_toxres_tfad015 crossref_primary_10_1615_CritRevOncog_2023050439 crossref_primary_10_1007_s00432_023_04791_2 crossref_primary_10_1007_s12032_023_02090_x crossref_primary_10_1016_j_imavis_2024_105193 crossref_primary_10_1021_acs_biomac_3c00988 crossref_primary_10_1016_j_bios_2023_115920 crossref_primary_10_1159_000541524 crossref_primary_10_1186_s40001_024_01930_4 crossref_primary_10_3390_antiox12010116 crossref_primary_10_3390_chemistry6040040 crossref_primary_10_3390_jpm13060968 crossref_primary_10_1186_s12885_024_12701_z crossref_primary_10_1016_j_tice_2025_102873 crossref_primary_10_1177_09731296241242542 crossref_primary_10_12677_acm_2024_14102824 crossref_primary_10_1039_D4CC06230B crossref_primary_10_1016_j_mcp_2022_101793 crossref_primary_10_3390_jcm11154398 crossref_primary_10_1016_j_bios_2025_117319 crossref_primary_10_1038_s41598_022_12301_6 crossref_primary_10_47992_IJMTS_2581_6012_0370 crossref_primary_10_3389_fgene_2023_1249678 crossref_primary_10_1016_j_advms_2024_09_007 crossref_primary_10_1016_j_ejphar_2023_175853 crossref_primary_10_1186_s12885_024_12416_1 crossref_primary_10_1186_s12935_024_03347_9 crossref_primary_10_3390_jpm14050446 crossref_primary_10_3390_ijms24032136 crossref_primary_10_3390_jcm12010037 crossref_primary_10_1155_2023_3377316 crossref_primary_10_1016_j_jep_2023_116739 crossref_primary_10_1016_j_aca_2025_343826 crossref_primary_10_1016_j_jpba_2024_116376 crossref_primary_10_1016_j_ijpharm_2025_125395 crossref_primary_10_3390_ijms24087050 crossref_primary_10_1097_MD_0000000000037218 crossref_primary_10_1186_s12885_023_11468_z crossref_primary_10_1016_j_aej_2024_05_110 crossref_primary_10_1093_bfgp_elad031 crossref_primary_10_3389_fmicb_2024_1353940 crossref_primary_10_3389_fonc_2024_1243432 crossref_primary_10_1016_j_pccm_2023_08_005 crossref_primary_10_1109_ACCESS_2024_3387702 crossref_primary_10_1186_s12890_023_02809_6 crossref_primary_10_1002_adfm_202313997 crossref_primary_10_56294_saludcyt2024_922 crossref_primary_10_5650_jos_ess23120 crossref_primary_10_1155_2022_7406636 crossref_primary_10_1177_15353702231184223 crossref_primary_10_1016_j_vaccine_2024_126690 crossref_primary_10_1007_s00595_022_02617_1 crossref_primary_10_1007_s11030_023_10789_2 crossref_primary_10_1097_MD_0000000000032772 crossref_primary_10_1039_D4MD00405A crossref_primary_10_61958_NCYO3401 crossref_primary_10_1038_s41419_024_07017_6 crossref_primary_10_1038_s41598_024_84539_1 crossref_primary_10_1186_s12931_025_03127_7 crossref_primary_10_1007_s11033_022_07933_w crossref_primary_10_1111_cas_16384 crossref_primary_10_3390_cancers16234048 crossref_primary_10_12688_f1000research_144432_1 crossref_primary_10_1016_j_cca_2024_120031 crossref_primary_10_1039_D3QI01777J crossref_primary_10_1111_cyt_13419 crossref_primary_10_2174_1570159X23666240905125037 crossref_primary_10_1007_s12032_024_02489_0 crossref_primary_10_1007_s13353_024_00847_2 crossref_primary_10_1007_s12668_024_01639_y crossref_primary_10_3390_diagnostics13152567 crossref_primary_10_3389_fimmu_2022_949553 crossref_primary_10_1007_s00259_023_06174_8 crossref_primary_10_3390_diagnostics15010001 crossref_primary_10_1016_j_tranon_2023_101728 crossref_primary_10_1080_17435889_2024_2348438 crossref_primary_10_3389_fgene_2022_917150 crossref_primary_10_1016_j_asjsur_2023_01_013 crossref_primary_10_1016_j_jpba_2024_115976 crossref_primary_10_1016_j_ijbiomac_2023_123633 crossref_primary_10_3389_fonc_2022_1005668 crossref_primary_10_1186_s12964_023_01368_x crossref_primary_10_1016_j_plabm_2024_e00409 crossref_primary_10_1016_j_jrras_2024_100911 crossref_primary_10_1007_s44272_024_00024_w crossref_primary_10_20473_jr_v10_I_1_2024_55_60 crossref_primary_10_3390_ijms24129843 crossref_primary_10_3390_jcm13206164 crossref_primary_10_3390_ijms25126664 crossref_primary_10_58742_bmj_v2i2_95 crossref_primary_10_2174_0113892010293337240312051931 crossref_primary_10_1002_mco2_70080 crossref_primary_10_1021_acsomega_4c04565 crossref_primary_10_1017_S1478951524001263 crossref_primary_10_1016_j_canep_2025_102770 crossref_primary_10_1016_j_intimp_2025_114498 crossref_primary_10_1038_s41598_023_49545_9 crossref_primary_10_18499_2225_7357_2024_13_1_19_27 crossref_primary_10_1155_2022_1163924 crossref_primary_10_1155_jcpt_8872458 crossref_primary_10_3390_bioengineering11111165 crossref_primary_10_3390_molecules27238295 crossref_primary_10_2174_0109298673278897231229121524 crossref_primary_10_1159_000540532 crossref_primary_10_1186_s12957_022_02868_9 crossref_primary_10_1039_D5AY00109A crossref_primary_10_1080_01932691_2024_2327428 crossref_primary_10_7717_peerj_16526 crossref_primary_10_1111_cyt_13335 crossref_primary_10_1080_17520363_2024_2404379 crossref_primary_10_32604_biocell_2023_045076 crossref_primary_10_1111_jcmm_18032 crossref_primary_10_2217_bmm_2024_0087 crossref_primary_10_3390_diagnostics13213318 crossref_primary_10_3389_fonc_2022_1031802 crossref_primary_10_5306_wjco_v16_i3_100361 crossref_primary_10_1155_2023_4010797 crossref_primary_10_1016_j_bioorg_2024_107480 crossref_primary_10_1002_cnma_202300378 crossref_primary_10_1515_tjb_2024_0076 crossref_primary_10_7759_cureus_42574 crossref_primary_10_1016_j_intimp_2024_113809 crossref_primary_10_1093_jpp_rgae141 crossref_primary_10_1186_s12885_023_11706_4 crossref_primary_10_1007_s12094_024_03752_6 crossref_primary_10_3892_wasj_2024_272 crossref_primary_10_2147_PGPM_S402750 crossref_primary_10_3390_ijms25179147 crossref_primary_10_1002_mco2_70020 crossref_primary_10_1080_10286020_2023_2193695 crossref_primary_10_1186_s12911_024_02553_9 crossref_primary_10_1093_carcin_bgae034 crossref_primary_10_1007_s12011_024_04082_y crossref_primary_10_4110_in_2023_23_e34 crossref_primary_10_3390_pharmaceutics16020260 crossref_primary_10_3892_mco_2024_2726 crossref_primary_10_7759_cureus_34768 crossref_primary_10_1039_D3BM00007A crossref_primary_10_18632_aging_205077 crossref_primary_10_1016_j_mcp_2024_101994 crossref_primary_10_1016_j_semcancer_2023_01_006 crossref_primary_10_1002_jbio_202300174 crossref_primary_10_3389_fimmu_2022_1025125 crossref_primary_10_1007_s44164_025_00086_7 crossref_primary_10_3390_molecules27217466 crossref_primary_10_1177_09636897231193066 crossref_primary_10_3389_fonc_2023_1228889 crossref_primary_10_3389_fpsyt_2024_1367858 crossref_primary_10_1371_journal_pone_0311755 crossref_primary_10_1155_2024_5195652 crossref_primary_10_1016_j_ijbiomac_2024_133918 crossref_primary_10_3390_jcm13144189 crossref_primary_10_1016_j_lungcan_2023_01_014 crossref_primary_10_3389_fonc_2023_1286821 crossref_primary_10_3390_ijms23031215 crossref_primary_10_3390_diagnostics14222497 crossref_primary_10_1186_s12967_024_04884_7 crossref_primary_10_1111_imm_13819 crossref_primary_10_1111_crj_13601 crossref_primary_10_1111_jcmm_18488 crossref_primary_10_1007_s12033_024_01088_8 crossref_primary_10_3390_jcm11206154 crossref_primary_10_1089_jir_2023_0043 crossref_primary_10_3892_ol_2024_14361 crossref_primary_10_2147_PGPM_S403868 crossref_primary_10_36416_1806_3756_e20230147 |
| Cites_doi | 10.1016/j.lungcan.2009.04.004 10.1016/j.cca.2020.04.005 10.1074/jbc.271.18.10760 10.1038/nrg2005 10.1039/c1mb05353a 10.1378/chest.89.4_Supplement.324S-a 10.1093/clinchem/48.11.1931 10.1093/annonc/mdy275 10.18632/oncoscience.98 10.1158/0008-5472.CAN-14-3781 10.1038/sj.bjc.6604351 10.1177/107327481402100102 10.1056/NEJMoa1801946 10.1186/s12885-015-1996-0 10.1093/jnci/90.13.991 10.1002/jcla.22990 10.1200/JCO.2002.20.4.911 10.3390/cancers13030506 10.1056/NEJMoa1102873 10.1016/j.lungcan.2009.11.009 10.1158/0008-5472.CAN-09-1378 10.1098/rsob.170070 10.1007/BF02599093 10.1016/S1470-2045(14)70387-0 10.1016/j.ypmed.2016.04.015 10.1016/S0169-5002(99)00058-6 10.1002/14651858.CD001991.pub3 10.1016/j.lungcan.2008.07.012 10.1007/s00216-015-8700-8 10.1177/1535370217750087 10.1016/S0021-9258(19)69802-9 10.1097/JTO.0000000000000405 10.1016/j.lungcan.2013.01.002 10.4155/fsoa-2018-0106 10.1038/bjc.1994.95 10.1371/journal.pone.0032695 10.3390/jpm11030182 10.1002/1097-0142(19930801)72:3<707::AID-CNCR2820720313>3.0.CO;2-X 10.1038/modpathol.2011.150 10.1245/s10434-010-0985-4 10.1186/s12885-018-4024-3 10.1158/1078-0432.CCR-10-0533 10.1200/JCO.2018.36.15_suppl.12003 10.1200/JCO.1988.6.11.1685 10.1158/1940-6207.CAPR-10-0170 10.1038/srep12270 10.3390/cancers12030622 10.1038/bjc.2013.393 10.3390/ijms20153821 10.1002/(SICI)1097-0142(19960401)77:7<1274::AID-CNCR7>3.0.CO;2-I 10.1634/theoncologist.2020-0193 10.1093/jnci/djz245 10.1016/j.lungcan.2016.02.006 10.1056/NEJMoa1916623 10.1016/j.biopha.2007.08.005 10.1038/s41419-019-1770-3 10.1634/theoncologist.2015-0523 10.6004/jnccn.2018.0020 10.1016/j.lungcan.2010.01.021 10.1593/neo.05586 10.1186/2047-783X-14-S4-237 10.1378/chest.108.1.163 10.1038/nm0996-1033 10.1016/j.lungcan.2017.06.006 10.1021/bi700256z 10.1200/EDBK_237863 10.1634/theoncologist.2011-0043 10.6026/97320630013202 10.1021/bi9612273 10.1139/y98-086 10.1016/S0169-5002(00)80835-1 10.3390/cancers11081069 10.1038/nrc.2017.7 10.1038/nm1556 10.2478/jomb-2018-0022 |
| ContentType | Journal Article |
| Copyright | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
| Copyright_xml | – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.3390/ijms22168661 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1422-0067 |
| ExternalDocumentID | PMC8395394 34445366 10_3390_ijms22168661 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: Mitacs grantid: IT22349 |
| GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c478t-f8a15a4fbd4c9ff20aac2ded2caa3a8a9cf16d2f592cc9613b61e2dd94aa6dd33 |
| IEDL.DBID | M48 |
| ISSN | 1422-0067 1661-6596 |
| IngestDate | Thu Aug 21 14:05:21 EDT 2025 Fri Jul 11 04:20:58 EDT 2025 Fri Jul 25 20:07:00 EDT 2025 Mon Jul 21 06:06:10 EDT 2025 Tue Jul 01 03:07:46 EDT 2025 Thu Apr 24 23:09:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 16 |
| Keywords | lung cancer predictors diagnosis body fluids imaging biomarkers |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c478t-f8a15a4fbd4c9ff20aac2ded2caa3a8a9cf16d2f592cc9613b61e2dd94aa6dd33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-7740-9299 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms22168661 |
| PMID | 34445366 |
| PQID | 2624242217 |
| PQPubID | 2032341 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8395394 proquest_miscellaneous_2566042261 proquest_journals_2624242217 pubmed_primary_34445366 crossref_citationtrail_10_3390_ijms22168661 crossref_primary_10_3390_ijms22168661 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20210812 |
| PublicationDateYYYYMMDD | 2021-08-12 |
| PublicationDate_xml | – month: 8 year: 2021 text: 20210812 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | International journal of molecular sciences |
| PublicationTitleAlternate | Int J Mol Sci |
| PublicationYear | 2021 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Cho (ref_43) 2007; 61 Liu (ref_63) 2006; 8 Ye (ref_11) 2019; 33 Crosbie (ref_8) 2017; 7 Spira (ref_66) 2007; 13 Nanavaty (ref_24) 2014; 21 Matsui (ref_79) 1981; 256 Schoenmakers (ref_53) 1994; 69 ref_57 ref_12 Morgensztern (ref_19) 2015; 10 Risse (ref_29) 1987; 31 Kulpa (ref_54) 2002; 48 Travis (ref_5) 2012; 25 Horeweg (ref_2) 2014; 15 Pulliero (ref_81) 2019; 60 Kennedy (ref_36) 2000; 1 ref_18 Hong (ref_45) 2011; 16 Sharp (ref_73) 2020; 507 Chen (ref_86) 2015; 2015 Hellmann (ref_40) 2018; 378 Tsoulos (ref_61) 2017; 38 Kumar (ref_58) 2010; 70 Xie (ref_64) 2010; 67 Johann (ref_46) 2018; 243 Wan (ref_55) 2017; 17 Wieskopf (ref_52) 1995; 108 Paci (ref_59) 2009; 64 Stieber (ref_49) 1993; 72 Tockman (ref_31) 1988; 6 ref_25 Flaherty (ref_21) 2020; 112 ref_22 Tockman (ref_62) 1986; 89 Bras (ref_78) 1998; 76 Kumar (ref_84) 2017; 13 Pegg (ref_80) 1982; 41 ref_28 Gazdar (ref_37) 2000; 6 Planchard (ref_39) 2018; 29 Wood (ref_10) 2018; 16 Esteller (ref_47) 2007; 8 Lenferink (ref_60) 2015; 5 Bras (ref_75) 2001; 29 Zhou (ref_32) 1996; 271 Swanton (ref_42) 2018; 36 Hubers (ref_56) 2013; 109 Ricciuti (ref_65) 2014; 1 Showe (ref_69) 2009; 69 Cameron (ref_83) 2016; 94 ref_72 Turck (ref_85) 2015; 407 Edge (ref_7) 2010; 17 Chen (ref_68) 1996; 2 Vujcic (ref_88) 1996; 35 Sobue (ref_26) 2002; 20 Zhang (ref_48) 2010; 69 ref_74 Howlader (ref_13) 2020; 383 Chan (ref_6) 2013; 5 Maksymiuk (ref_76) 2018; 5 Horn (ref_16) 2016; 21 Melosky (ref_17) 2020; 25 Rotunno (ref_67) 2011; 4 Venmans (ref_34) 1998; 5 Alborelli (ref_41) 2019; 10 Pennell (ref_20) 2019; 39 Vermylen (ref_35) 1999; 25 Zander (ref_70) 2011; 17 Hegde (ref_77) 2007; 46 Toyoda (ref_27) 2008; 98 ref_89 ref_44 Dragoj (ref_14) 2019; 38 ref_87 MacDougall (ref_30) 1992; 7 Miller (ref_23) 2016; 89 Kurie (ref_33) 1998; 90 Muraki (ref_51) 1996; 77 ref_1 Bertolini (ref_82) 2015; 75 ref_3 Keller (ref_71) 2011; 7 Messner (ref_38) 2016; 10 ref_9 Kim (ref_15) 2017; 110 Okamura (ref_50) 2013; 80 ref_4 |
| References_xml | – volume: 10 start-page: 19 year: 2016 ident: ref_38 article-title: Barriers to Clinical Adoption of next Generation Sequencing: Perspectives of a Policy Delphi Panel publication-title: Appl. Transl. Genom. – volume: 67 start-page: 170 year: 2010 ident: ref_64 article-title: Altered MiRNA Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer publication-title: Lung Cancer doi: 10.1016/j.lungcan.2009.04.004 – volume: 507 start-page: 1 year: 2020 ident: ref_73 article-title: ELISA-Based Detection of Open Reading Frame Protein 1 in Patients at Risk of Developing Lung Cancer publication-title: Clin. Chim. Acta doi: 10.1016/j.cca.2020.04.005 – volume: 271 start-page: 10760 year: 1996 ident: ref_32 article-title: Purification and Characterization of a Protein That Permits Early Detection of Lung Cancer: Identification of Heterogeneous Nuclear Ribonucleoprotein-A2/B1 as the Antigen for Monoclonal Antibody 703D4 publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.18.10760 – volume: 8 start-page: 286 year: 2007 ident: ref_47 article-title: Cancer Epigenomics: DNA Methylomes and Histone-Modification Maps publication-title: Nat. Rev. Genet. doi: 10.1038/nrg2005 – volume: 7 start-page: 3187 year: 2011 ident: ref_71 article-title: Next-Generation Sequencing Identifies Novel MicroRNAs in Peripheral Blood of Lung Cancer Patients publication-title: Mol. BioSyst. doi: 10.1039/c1mb05353a – volume: 89 start-page: 324S year: 1986 ident: ref_62 article-title: Survival and Mortality from Lung Cancer in a Screened Population: The Johns Hopkins Study publication-title: Chest doi: 10.1378/chest.89.4_Supplement.324S-a – volume: 48 start-page: 1931 year: 2002 ident: ref_54 article-title: Carcinoembryonic Antigen, Squamous Cell Carcinoma Antigen, CYFRA 21-1, and Neuron-Specific Enolase in Squamous Cell Lung Cancer Patients publication-title: Clin. Chem. doi: 10.1093/clinchem/48.11.1931 – volume: 29 start-page: iv192 year: 2018 ident: ref_39 article-title: Metastatic Non-Small Cell Lung Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up publication-title: Ann. Oncol. doi: 10.1093/annonc/mdy275 – volume: 1 start-page: 674 year: 2014 ident: ref_65 article-title: Non-Coding RNAs in Lung Cancer publication-title: Oncoscience doi: 10.18632/oncoscience.98 – volume: 75 start-page: 3636 year: 2015 ident: ref_82 article-title: Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-3781 – volume: 98 start-page: 1602 year: 2008 ident: ref_27 article-title: Sensitivity and Specificity of Lung Cancer Screening Using Chest Low-Dose Computed Tomography publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6604351 – volume: 21 start-page: 9 year: 2014 ident: ref_24 article-title: Lung Cancer Screening: Advantages, Controversies, and Applications publication-title: Cancer Control doi: 10.1177/107327481402100102 – volume: 60 start-page: E327 year: 2019 ident: ref_81 article-title: Extracellular Vesicles in Biological Fluids. A Biomarker of Exposure to Cigarette Smoke and Treatment with Chemopreventive Drugs publication-title: J. Prev. Med. Hyg. – volume: 378 start-page: 2093 year: 2018 ident: ref_40 article-title: Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1801946 – volume: 6 start-page: 1611 year: 2000 ident: ref_37 article-title: Angiogenesis and the Multistage Development of Lung Cancers publication-title: Clin. Cancer Res. – ident: ref_1 – ident: ref_74 doi: 10.1186/s12885-015-1996-0 – volume: 90 start-page: 991 year: 1998 ident: ref_33 article-title: Autofluorescence Bronchoscopy in the Detection of Squamous Metaplasia and Dysplasia in Current and Former Smokers publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/90.13.991 – volume: 33 start-page: e22990 year: 2019 ident: ref_11 article-title: Identification of a Multidimensional Transcriptome Prognostic Signature for Lung Adenocarcinoma publication-title: J. Clin. Lab. Anal. doi: 10.1002/jcla.22990 – volume: 20 start-page: 911 year: 2002 ident: ref_26 article-title: Screening for Lung Cancer with Low-Dose Helical Computed Tomography: Anti-Lung Cancer Association Project publication-title: JCO doi: 10.1200/JCO.2002.20.4.911 – ident: ref_12 doi: 10.3390/cancers13030506 – ident: ref_28 doi: 10.1056/NEJMoa1102873 – volume: 69 start-page: 225 year: 2010 ident: ref_48 article-title: Value of Quantitative Analysis of Circulating Cell Free DNA as a Screening Tool for Lung Cancer: A Meta-Analysis publication-title: Lung Cancer doi: 10.1016/j.lungcan.2009.11.009 – volume: 69 start-page: 9202 year: 2009 ident: ref_69 article-title: Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-1378 – ident: ref_4 – volume: 7 start-page: 170070 year: 2017 ident: ref_8 article-title: Progress and Prospects of Early Detection in Lung Cancer publication-title: Open Biol. doi: 10.1098/rsob.170070 – volume: 7 start-page: 11 year: 1992 ident: ref_30 article-title: The Value of Sputum Cytology publication-title: J. Gen. Intern. Med. doi: 10.1007/BF02599093 – volume: 15 start-page: 1342 year: 2014 ident: ref_2 article-title: Detection of Lung Cancer through Low-Dose CT Screening (NELSON): A Prespecified Analysis of Screening Test Performance and Interval Cancers publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(14)70387-0 – volume: 89 start-page: 301 year: 2016 ident: ref_23 article-title: Screening for Lung Cancer: A Systematic Review and Meta-Analysis publication-title: Prev. Med. doi: 10.1016/j.ypmed.2016.04.015 – volume: 25 start-page: 161 year: 1999 ident: ref_35 article-title: Detection of Bronchial Preneoplastic Lesions and Early Lung Cancer with Fluorescence Bronchoscopy: A Study about Its Ambulatory Feasibility under Local Anaesthesis publication-title: Lung Cancer doi: 10.1016/S0169-5002(99)00058-6 – volume: 5 start-page: 280 year: 1998 ident: ref_34 article-title: Early Detection of Preinvasive Lesions in High-Risk Patients: A Comparison of Conventional Flexible and Fluorescence Bronchoscopy publication-title: J. Bronchol. Interv. Pulmonol. – volume: 29 start-page: 676 year: 2001 ident: ref_75 article-title: Spermidine/SpermineN 1-Acetyltransferase Catalyzes Amantadine Acetylation publication-title: Drug Metab. Dispos. – ident: ref_9 doi: 10.1002/14651858.CD001991.pub3 – volume: 64 start-page: 92 year: 2009 ident: ref_59 article-title: Circulating Plasma DNA as Diagnostic Biomarker in Non-Small Cell Lung Cancer publication-title: Lung Cancer doi: 10.1016/j.lungcan.2008.07.012 – volume: 407 start-page: 5381 year: 2015 ident: ref_85 article-title: Human Sweat Metabolomics for Lung Cancer Screening publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-015-8700-8 – volume: 41 start-page: 3065 year: 1982 ident: ref_80 article-title: Polyamine Biosynthesis and Interconversion in Rodent Tissues publication-title: Fed. Proc. – volume: 243 start-page: 262 year: 2018 ident: ref_46 article-title: Liquid Biopsy and Its Role in an Advanced Clinical Trial for Lung Cancer publication-title: Exp. Biol. Med. doi: 10.1177/1535370217750087 – volume: 256 start-page: 2454 year: 1981 ident: ref_79 article-title: Properties of Spermidine N-Acetyltransferase from Livers of Rats Treated with Carbon Tetrachloride and Its Role in the Conversion of Spermidine into Putrescine publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)69802-9 – volume: 10 start-page: S1 year: 2015 ident: ref_19 article-title: Molecularly Targeted Therapies in Non-Small-Cell Lung Cancer Annual Update 2014 publication-title: J. Thorac. Oncol. doi: 10.1097/JTO.0000000000000405 – volume: 80 start-page: 45 year: 2013 ident: ref_50 article-title: Diagnostic Value of CEA and CYFRA 21-1 Tumor Markers in Primary Lung Cancer publication-title: Lung Cancer doi: 10.1016/j.lungcan.2013.01.002 – volume: 5 start-page: FSO365 year: 2018 ident: ref_76 article-title: Use of Amantadine as Substrate for SSAT-1 Activity as a Reliable Clinical Diagnostic Assay for Breast and Lung Cancer publication-title: Future Sci. OA doi: 10.4155/fsoa-2018-0106 – volume: 69 start-page: 525 year: 1994 ident: ref_53 article-title: Evaluation of a New Tumour Marker in Patients with Non-Small-Cell Lung Cancer: Cyfra 21.1 publication-title: Br. J. Cancer doi: 10.1038/bjc.1994.95 – ident: ref_18 doi: 10.1371/journal.pone.0032695 – ident: ref_72 doi: 10.3390/jpm11030182 – volume: 72 start-page: 707 year: 1993 ident: ref_49 article-title: CYFRA 21-1: A New Marker in Lung Cancer publication-title: Cancer doi: 10.1002/1097-0142(19930801)72:3<707::AID-CNCR2820720313>3.0.CO;2-X – ident: ref_3 – volume: 25 start-page: S18 year: 2012 ident: ref_5 article-title: Update on Small Cell Carcinoma and Its Differentiation from Squamous Cell Carcinoma and Other Non-Small Cell Carcinomas publication-title: Mod. Pathol. doi: 10.1038/modpathol.2011.150 – volume: 17 start-page: 1471 year: 2010 ident: ref_7 article-title: The American Joint Committee on Cancer: The 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-010-0985-4 – ident: ref_44 doi: 10.1186/s12885-018-4024-3 – volume: 38 start-page: 3419 year: 2017 ident: ref_61 article-title: Tumor Molecular Profiling of NSCLC Patients Using next Generation Sequencing publication-title: Oncol. Rep. – volume: 17 start-page: 3360 year: 2011 ident: ref_70 article-title: Blood-Based Gene Expression Signatures in Non-Small Cell Lung Cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-0533 – volume: 36 start-page: 12003 year: 2018 ident: ref_42 article-title: Prevalence of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Measured by an Ultra-Sensitive Sequencing Assay: Exploratory Analysis of the Circulating Cancer Genome Atlas (CCGA) Study publication-title: JCO doi: 10.1200/JCO.2018.36.15_suppl.12003 – volume: 6 start-page: 1685 year: 1988 ident: ref_31 article-title: Sensitive and Specific Monoclonal Antibody Recognition of Human Lung Cancer Antigen on Preserved Sputum Cells: A New Approach to Early Lung Cancer Detection publication-title: J. Clin. Oncol. doi: 10.1200/JCO.1988.6.11.1685 – volume: 4 start-page: 1599 year: 2011 ident: ref_67 article-title: A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma publication-title: Cancer Prev. Res. doi: 10.1158/1940-6207.CAPR-10-0170 – volume: 5 start-page: 12270 year: 2015 ident: ref_60 article-title: The Detection of EpCAM+ and EpCAM− Circulating Tumor Cells publication-title: Sci. Rep. doi: 10.1038/srep12270 – ident: ref_89 doi: 10.3390/cancers12030622 – volume: 109 start-page: 530 year: 2013 ident: ref_56 article-title: Molecular Sputum Analysis for the Diagnosis of Lung Cancer publication-title: Br. J. Cancer doi: 10.1038/bjc.2013.393 – ident: ref_22 doi: 10.3390/ijms20153821 – volume: 77 start-page: 1274 year: 1996 ident: ref_51 article-title: Assessment of Serum CYFRA 21-1 in Lung Cancer publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19960401)77:7<1274::AID-CNCR7>3.0.CO;2-I – volume: 31 start-page: 170 year: 1987 ident: ref_29 article-title: Relationship between the Cellular Composition of Sputum and the Cytologic Diagnosis of Lung Cancer publication-title: Acta Cytol. – volume: 25 start-page: 981 year: 2020 ident: ref_17 article-title: Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-stage Small Cell Lung Cancer publication-title: Oncologist doi: 10.1634/theoncologist.2020-0193 – volume: 112 start-page: 1021 year: 2020 ident: ref_21 article-title: The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djz245 – volume: 94 start-page: 88 year: 2016 ident: ref_83 article-title: The Metabolomic Detection of Lung Cancer Biomarkers in Sputum publication-title: Lung Cancer doi: 10.1016/j.lungcan.2016.02.006 – volume: 383 start-page: 640 year: 2020 ident: ref_13 article-title: The Effect of Advances in Lung-Cancer Treatment on Population Mortality publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1916623 – volume: 61 start-page: 515 year: 2007 ident: ref_43 article-title: Potentially Useful Biomarkers for the Diagnosis, Treatment and Prognosis of Lung Cancer publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2007.08.005 – volume: 10 start-page: 534 year: 2019 ident: ref_41 article-title: Cell-Free DNA Analysis in Healthy Individuals by next-Generation Sequencing: A Proof of Concept and Technical Validation Study publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1770-3 – volume: 21 start-page: 910 year: 2016 ident: ref_16 article-title: The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer publication-title: Oncologist doi: 10.1634/theoncologist.2015-0523 – volume: 16 start-page: 412 year: 2018 ident: ref_10 article-title: Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology publication-title: J. Natl. Compr. Cancer Netw. doi: 10.6004/jnccn.2018.0020 – ident: ref_25 – volume: 70 start-page: 211 year: 2010 ident: ref_58 article-title: Efficacy of Circulating Plasma DNA as a Diagnostic Tool for Advanced Non-Small Cell Lung Cancer and Its Predictive Utility for Survival and Response to Chemotherapy publication-title: Lung Cancer doi: 10.1016/j.lungcan.2010.01.021 – volume: 8 start-page: 46 year: 2006 ident: ref_63 article-title: Aberrant Promoter Methylation of P16 and MGMT Genes in Lung Tumors from Smoking and Never-Smoking Lung Cancer Patients publication-title: Neoplasia doi: 10.1593/neo.05586 – ident: ref_57 doi: 10.1186/2047-783X-14-S4-237 – volume: 108 start-page: 163 year: 1995 ident: ref_52 article-title: Cyfra 21-1 as a Biologic Marker of Non-Small Cell Lung Cancer: Evaluation of Sensitivity, Specificity, and Prognostic Role publication-title: Chest doi: 10.1378/chest.108.1.163 – volume: 2 start-page: 1033 year: 1996 ident: ref_68 article-title: Microsatellite Alterations in Plasma DNA of Small Cell Lung Cancer Patients publication-title: Nat. Med. doi: 10.1038/nm0996-1033 – volume: 110 start-page: 63 year: 2017 ident: ref_15 article-title: MYC Expression Correlates with PD-L1 Expression in Non-Small Cell Lung Cancer publication-title: Lung Cancer doi: 10.1016/j.lungcan.2017.06.006 – volume: 46 start-page: 7187 year: 2007 ident: ref_77 article-title: Mechanistic and Structural Analysis of Human Spermidine/Spermine N1-Acetyltransferase [HSSAT] publication-title: Biochemistry doi: 10.1021/bi700256z – volume: 39 start-page: 531 year: 2019 ident: ref_20 article-title: Biomarker Testing for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Issues and Tough Choices publication-title: Am. Soc. Clin. Oncol. Educ. Book doi: 10.1200/EDBK_237863 – volume: 16 start-page: 1292 year: 2011 ident: ref_45 article-title: Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience publication-title: Oncologist doi: 10.1634/theoncologist.2011-0043 – volume: 13 start-page: 202 year: 2017 ident: ref_84 article-title: Serum and Plasma Metabolomic Biomarkers for Lung Cancer publication-title: Bioinformation doi: 10.6026/97320630013202 – volume: 2015 start-page: 183624 year: 2015 ident: ref_86 article-title: Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer publication-title: BioMed Res. Int. – volume: 35 start-page: 14436 year: 1996 ident: ref_88 article-title: Effects of Polyamines, Polyamine Analogs, and Inhibitors of Protein Synthesis on Spermidine−Spermine N1-Acetyltransferase Gene Expression publication-title: Biochemistry doi: 10.1021/bi9612273 – volume: 76 start-page: 701 year: 1998 ident: ref_78 article-title: Amantadine Acetylation May Be Effected by Acetyltransferases Other than NAT1 or NAT2 publication-title: Can. J. Physiol. Pharmacol. doi: 10.1139/y98-086 – volume: 1 start-page: 244 year: 2000 ident: ref_36 article-title: A Randomized Study of Fluorescence Bronchoscopy versus White-Light Bronchoscopy for Early Detection of Lung Cancer in High Risk Patients publication-title: Lung Cancer doi: 10.1016/S0169-5002(00)80835-1 – ident: ref_87 doi: 10.3390/cancers11081069 – volume: 5 start-page: S565 year: 2013 ident: ref_6 article-title: Chemotherapy Advances in Small-Cell Lung Cancer publication-title: J. Thorac. Dis. – volume: 17 start-page: 223 year: 2017 ident: ref_55 article-title: Liquid Biopsies Come of Age: Towards Implementation of Circulating Tumour DNA publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2017.7 – volume: 13 start-page: 361 year: 2007 ident: ref_66 article-title: Airway Epithelial Gene Expression in the Diagnostic Evaluation of Smokers with Suspect Lung Cancer publication-title: Nat. Med. doi: 10.1038/nm1556 – volume: 38 start-page: 188 year: 2019 ident: ref_14 article-title: Association of Overexpressed MYC Gene with Altered PHACTR3 and E2F4 Genes Contributes to Non-Small Cell Lung Carcinoma Pathogenesis publication-title: J. Med. Biochem. doi: 10.2478/jomb-2018-0022 |
| SSID | ssj0023259 |
| Score | 2.708779 |
| SecondaryResourceType | review_article |
| Snippet | Lung cancer is the leading cause of cancer-related deaths in North America and other developed countries. One of the reasons lung cancer is at the top of the... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 8661 |
| SubjectTerms | Biomarkers Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Biopsy Cancer therapies Chemotherapy Diagnostic Imaging Disease Progression Early Detection of Cancer Gene amplification Humans Lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - etiology Lung Neoplasms - genetics Lung Neoplasms - metabolism Lymphatic system Medical prognosis Medical screening Metastasis Mutation Occupational Diseases - diagnosis Occupational Diseases - etiology Radiation Review Risk Factors Smoking - adverse effects Smoking - epidemiology Tumors |
| SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDI5gCIkL4s1goCDBCUVb82pzQmgwJgScmLRblSaNGIJu7HHg3-O0XdlAcLaVRnYS28nXzwidR5oJqBIcoSqwBEKAIQl3LeKgvk6shFM5J6t-fJLdHr_vi3554TYpYZXzMzE_qO3Q-DvyJs1_ZKCQQV-NPojvGuVfV8sWGqtoLYBI4yFdUeeuKrgYzZulBRCDiBRKFsB3BtNoDl7fJzCYjKQMlkPSrzzzJ1xyIf50ttBmmTji68LT22glzXbQetFK8nMXhSXREtaZxZ2cKAQvAILwIMMPsK9x23t5jG8KhN1gsod6ndvndpeUTRGI4WE0JS7SgdDcJZYb5RxtaW2oBZMarZmOtDIukJY6oagxCoJ1IoOUWqu41tJaxvZRLRtm6SHCQjEmQJgI_9aXuCh0NrBCWAl1jkrDOrqc2yU2JWO4b1zxFkPl4K0YL1qxji4q7VHBlPGHXmNu4rjcL5P427t1dFaJYaX75wudpcMZ6EDm6RnL_BAHhUeqDzHOuWBS1lG45KtKwbNoL0uywUvOpg0ZomCKH_0_rWO0QT2axZPh0gaqTcez9ATSkWlymq-5L6Pi37g priority: 102 providerName: ProQuest |
| Title | Current and Future Development in Lung Cancer Diagnosis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34445366 https://www.proquest.com/docview/2624242217 https://www.proquest.com/docview/2566042261 https://pubmed.ncbi.nlm.nih.gov/PMC8395394 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwED5tqybtBQ3YoDAqI8ETylj8K_HDhKCsTIhWaFqlvkWOHWtFI9vaTtr--90ladQykHjJiy92dGf77rMv3wG8S61QiBJCxE3sI3QBLsplOIoC4uvca9yVK7Lq4UifjuX3iZpswLLaaKPA-V-hHdWTGs8uD-9u7j_hgj8mxIldfpz--j3nPNapJhzUQZ-UUC2DoWzvEzBsqMqm0YFHRBt0nQL_6O115_Qo4vwzcXLFEw124UkTQrLPtc2fwkZRPoPtuqjk_XNIGsolZkvPBhVlCFtJDWLTkv3AFc76ZO8Z-1rn2k3nezAenJz3T6OmPELkZJIuopDaWFkZci-dCYEfWeu4R-U6a4VNrXEh1p4HZbhzBt12ruOCe2-ktdp7IfZhq7wqi5fAlBFCYWOu6NYvD2kSfOyV8hoRjymSLnxY6iVzDXc4lbC4zBBDkBazVS124X0rfV1zZvxD7mCp4mxp-IxXP6ygCA76tm3GOU8XGbYsrm5RBmNQ4i6jLl7UFmkHElJKJbTuQrJmq1aA-LTXW8rpRcWrjbGiEka--s_Pfw07nBJciB-XH8DWYnZbvMEIZZH3YDOZJPhMB9960PlyMvp51iOfoXrVtHwAs57pcQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LTxsxEB4hUEUviLbQBmhrpHKqLLJ-7fpQIQRNAwROIHFbvPZapGo3QBKh_Cl-Y8f7atKqvXH2aNeaGc_DM_4G4FNiuMQswVOmI0fRBViaCd-lHvPrzCm0yiVY9fmF6l-J02t5vQRPzVuY0FbZ2MTSULuRDXfk-6x8yMAwgj64u6dhalSorjYjNCq1OMtnj5iyjb-cHKN89xjrfb086tN6qgC1Ik4m1Ccmkkb4zAmrvWddYyxzuCdrDDeJ0dZHyjEvNbNWo7fLVJQz57QwRjkXLkDR5K8Ijp48vEzvfWsTPM7K4WwR-jyqpFZVoz0SdveH33-OcfMqUSpadIF_xbV_tmfO-bveOqzVgSo5rDTrFSzlxWt4UY2unL2BuAZ2IqZwpFcCk5C5BiQyLMgA7Qg5Clr1QI6rjr7heAOunoVdm7BcjIr8HRCpOZe4mMlQW8x8EnsXOSmdwrxK53EHPjd8SW2NUB4GZfxIMVMJXEznudiBvZb6rkLm-AfdTsPitD6f4_S3NnVgt13GkxXKJabIR1OkwUg3IKSFT7ytJNL-iAshJFeqA_GCrFqCgNq9uFIMb0v0boxIJddi6__b-gir_cvzQTo4uTjbhpcsdNIEIF62A8uTh2n-HkOhSfah1D8CN8-t8L8AvaMgGw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB5VqUC9IF5tUwIYiZ6Qla5fuz4gBE2jlpaoQlTqbeu112pQu0mbRKh_jV_HeF8kILj17NGudzyex_rzNwBvE8MlVgmeMh05iiHA0kz4Peqxvs6cQq9cklV_GanDM_H5XJ6vwc_mLkyAVTY-sXTUbmLDP_I-Ky8yMMyg-76GRZwOhh-mNzR0kAonrU07jcpEjvO7H1i-zd4fDXCtdxkbHnzbP6R1hwFqRZzMqU9MJI3wmRNWe8_2jLHM4fysMdwkRlsfKce81MxajZEvU1HOnNPCGOVc-BmK7n89DlVRB9Y_HYxOv7blHmdlq7YIIyBVUqsKds9RCf3x9-sZfopKlIpWA-JfWe6fYM2l6Dd8DI_qtJV8rOzsCazlxVN4UDWyvHsGcU3zREzhyLCkKSFLcCQyLsgJehWyH2zslgwqfN949hzO7kVhm9ApJkW-DURqziUOZjKcNGY-ib2LnJROYZWl87gL7xq9pLbmKw9tM65SrFuCFtNlLXZht5WeVjwd_5DrNSpO6906S3_bVhfetMO4z8LhiSnyyQJlMO8NfGnhEVvVirQv4kIIyZXqQryyVq1A4PBeHSnGlyWXN-ankmux8_9pvYaHaOzpydHo-AVssACrCay8rAed-e0if4l50Tx7VRsggYv7tvlflOAlrQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+and+Future+Development+in+Lung+Cancer+Diagnosis&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Nooreldeen%2C+Reem&rft.au=Bach%2C+Horacio&rft.date=2021-08-12&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=22&rft.issue=16&rft.spage=8661&rft_id=info:doi/10.3390%2Fijms22168661&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms22168661 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |